Analysts who follow Corvus Pharmaceuticals Inc (CRVS) on average expect it to rise 146.21% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.
That average rating earns CRVS an Analyst Ranking of 78, which means it ranks higher than 78 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.
InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.
What's Happening With Corvus Pharmaceuticals Inc Stock Today?
Corvus Pharmaceuticals Inc (CRVS) stock is trading at $3.96 as of 1:14 PM on Thursday, Feb 11, a decline of -$0.19, or -4.58% from the previous closing price of $4.15. The stock has traded between $3.92 and $4.32 so far today. Volume today is 394,181 compared to average volume of 361,959.
Click Here to get the full report on Corvus Pharmaceuticals Inc (CRVS) Stock.
